Phase 5: Stabilize & govern · Step 5.1
Set a spending growth target
Annual, starting Year 5 · Payment Rates Board; Congress (veto)Discuss this step
fiscallikelihood: mediumimpact: high
Costs come in at the costly case
Provider lobbying raises rates, induced demand is higher, and drug savings are smaller. The ledger's costly case adds about $842.8B a year in required general revenue.
Early warning signs
- First-year actual vs. ledger by line
- Rates Board recommendations overridden
Mitigation
- Automatic household-premium adjustment
- Standby copay option
- Spending growth target
Implementation risks
| Risk | Mitigation |
|---|---|
| Repeated congressional overrides (the SGR precedent). | Overrides require offsets within the Trust Fund. |